2B70:XETRA:XETRA-iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (EUR)

ETF | Others |

Last Closing

USD 5.962

Change

-0.05 (-0.85)%

Market Cap

USD 0.52B

Volume

0.09M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

ETFs Containing 2B70:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.47% 40% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.47% 40% F 42% F
Trailing 12 Months  
Capital Gain 9.13% 42% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.13% 42% F 45% F
Trailing 5 Years  
Capital Gain 43.28% 59% D- 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 43.28% 57% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 6.33% 60% D- 58% F
Dividend Return 6.33% 58% F 56% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.42% 43% F 54% F
Risk Adjusted Return 43.91% 55% F 58% F
Market Capitalization 0.52B 68% D+ 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.